Related Experiment Videos
Pregnancy in association with mitral valve prolapse
1Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Asia-Oceania Journal of Obstetrics and Gynaecology
|March 1, 1993
Summary
Mitral valve prolapse (MVP) in pregnant women is common and generally well-tolerated. Careful monitoring and management are key to ensuring positive outcomes for both mother and baby.
Area of Science:
- Cardiology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Mitral valve prolapse (MVP) is the most prevalent valvular heart disease in women of reproductive age.
- Pregnancy in women with MVP presents unique considerations for cardiovascular health.
Purpose of the Study:
- To review the obstetrical performance and outcomes of pregnancies in women diagnosed with mitral valve prolapse.
- To identify potential complications and management strategies for pregnant individuals with MVP.
Main Methods:
- Retrospective review of 34 pregnancies in 15 women with diagnosed MVP.
- Analysis of maternal cardiac status, pregnancy course, labor, and neonatal outcomes.
Main Results:
- Most women with MVP tolerated pregnancy and labor well, with few requiring medication for arrhythmias.
- A small percentage of pregnancies resulted in spontaneous abortion or intrauterine fetal death, often linked to severe pregnancy-induced hypertension.
- Neonatal outcomes were generally favorable, with most infants born at term and without congenital abnormalities.
Conclusions:
- Mitral valve prolapse in pregnancy is typically manageable with appropriate cardiovascular monitoring and care.
- Early detection of cardiac issues and prompt treatment of arrhythmias are crucial for preventing severe maternal complications.
- Prophylaxis against infective endocarditis is recommended for those with mitral regurgitation and complicated deliveries.